FI875086A7 - Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. - Google Patents
Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. Download PDFInfo
- Publication number
- FI875086A7 FI875086A7 FI875086A FI875086A FI875086A7 FI 875086 A7 FI875086 A7 FI 875086A7 FI 875086 A FI875086 A FI 875086A FI 875086 A FI875086 A FI 875086A FI 875086 A7 FI875086 A7 FI 875086A7
- Authority
- FI
- Finland
- Prior art keywords
- farmaceutiska
- benzotiadiazinfoereningar
- blandningar
- nya
- foerfarande foer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868627857A GB8627857D0 (en) | 1986-11-21 | 1986-11-21 | Benzothiadiazine compounds |
| GB878714598A GB8714598D0 (en) | 1987-06-22 | 1987-06-22 | Benzothiadiazine compounds |
| GB878720659A GB8720659D0 (en) | 1987-09-02 | 1987-09-02 | Benzothiadiazine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI875086A0 FI875086A0 (fi) | 1987-11-18 |
| FI875086A7 true FI875086A7 (fi) | 1988-05-22 |
Family
ID=27263212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI875086A FI875086A7 (fi) | 1986-11-21 | 1987-11-18 | Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4889851A (fi) |
| EP (1) | EP0268990A3 (fi) |
| JP (1) | JP2564860B2 (fi) |
| KR (1) | KR880006219A (fi) |
| CN (1) | CN87107990A (fi) |
| AU (1) | AU603842B2 (fi) |
| DK (1) | DK597387A (fi) |
| FI (1) | FI875086A7 (fi) |
| NO (1) | NO874850L (fi) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ223237A (en) * | 1987-01-22 | 1991-03-26 | Shiseido Co Ltd | Hair growth promoting agent and compositions |
| AU5883794A (en) * | 1993-01-20 | 1994-08-15 | A. Menarini Industrie Farmaceutiche Riunite S.R.L. | Diazepin derivatives and antiviral compositions |
| FR2710062B1 (fr) * | 1993-09-17 | 1995-12-01 | Rhone Poulenc Rorer Sa | Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant. |
| US6008208A (en) | 1995-10-23 | 1999-12-28 | Osteoscreen, Inc. | Compositions and methods for treating bone deficit conditions |
| PL327617A1 (en) * | 1995-10-23 | 1998-12-21 | Zymogenetics Inc | Compositions for and methods of treating osseous insufficiency |
| EP0973513A4 (en) * | 1996-10-23 | 2003-03-19 | Zymogenetics Inc | COMPILATIONS AND METHOD FOR TREATING BONE DEFICIENCY |
| JP2002514192A (ja) * | 1996-11-13 | 2002-05-14 | セフアロン・インコーポレーテツド | ベンゾチアゾおよび関連の複素環基を含有するシステインおよびセリンプロテアーゼ阻害剤 |
| US5952328A (en) * | 1997-11-12 | 1999-09-14 | Cephalon, Inc. | Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| BR0010700A (pt) | 1999-04-30 | 2002-02-13 | Slil Biomedical Corp | Conjugados análogos de poliamina e conjugados de quinona como terapias para cânceres e doenças na próstata |
| WO2002047696A1 (de) * | 2000-12-16 | 2002-06-20 | Aventis Pharma Deutschland Gmbh | Verwendung von niedermolekularen heparin zur behandlung von osteoarthrose |
| US20030130356A1 (en) * | 2001-10-16 | 2003-07-10 | Slil Biomedical Corporation | Oligoamine compounds and derivatives thereof for cancer therapy |
| KR100787130B1 (ko) * | 2006-03-23 | 2007-12-21 | 한국화학연구원 | 신규의 치환된 1,1-다이옥소-벤조[1,2,4]티아디아진-3-온, 이의 제조방법 및 이를 포함하는 약학적 조성물 |
| UA100120C2 (en) * | 2007-04-03 | 2012-11-26 | Анадис Фармасьютикалз, Инк. | 5,6-dihydro-1h-pyridin-2-one compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1067028B (fi) * | 1959-10-15 | |||
| US3296070A (en) * | 1967-01-03 | Method for the treatment of hypertension | ||
| US3287362A (en) * | 1966-11-22 | Substituted j-oxo-j,x-dihydro-l,z,x-benzo- thiadiazine i,i-dioxides and a method for their preparation | ||
| US3267096A (en) * | 1965-02-24 | 1966-08-16 | Miles Lab | Derivatives of 2h, 4h-benzothiadiazine 1, 1-dioxide |
| FR5571M (fi) * | 1965-12-23 | 1967-11-27 | ||
| US3892738A (en) * | 1972-03-20 | 1975-07-01 | Merck & Co Inc | 7-Thiasubstituted-1,2,4-benzothiadiazine-1,1-dioxides and their salts |
| GB8524663D0 (en) * | 1985-10-07 | 1985-11-13 | Fujisawa Pharmaceutical Co | Quinazoline derivatives |
-
1987
- 1987-11-05 US US07/116,913 patent/US4889851A/en not_active Expired - Fee Related
- 1987-11-13 DK DK597387A patent/DK597387A/da not_active Application Discontinuation
- 1987-11-18 FI FI875086A patent/FI875086A7/fi not_active IP Right Cessation
- 1987-11-18 EP EP87117019A patent/EP0268990A3/en not_active Withdrawn
- 1987-11-20 CN CN198787107990A patent/CN87107990A/zh active Pending
- 1987-11-20 KR KR1019870013086A patent/KR880006219A/ko not_active Withdrawn
- 1987-11-20 JP JP62294588A patent/JP2564860B2/ja not_active Expired - Lifetime
- 1987-11-20 NO NO874850A patent/NO874850L/no unknown
- 1987-11-20 AU AU81465/87A patent/AU603842B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN87107990A (zh) | 1988-06-01 |
| DK597387D0 (da) | 1987-11-13 |
| DK597387A (da) | 1988-05-22 |
| US4889851A (en) | 1989-12-26 |
| JP2564860B2 (ja) | 1996-12-18 |
| EP0268990A3 (en) | 1988-08-10 |
| NO874850L (no) | 1988-05-24 |
| JPS63183572A (ja) | 1988-07-28 |
| KR880006219A (ko) | 1988-07-22 |
| AU8146587A (en) | 1988-05-26 |
| EP0268990A2 (en) | 1988-06-01 |
| FI875086A0 (fi) | 1987-11-18 |
| NO874850D0 (no) | 1987-11-20 |
| AU603842B2 (en) | 1990-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI880546A7 (fi) | Nya kolfibriller, foerfarande foer framstaellning daerav och kompositioner innehaollande desamma. | |
| FI873142A7 (fi) | Nya benzolsulfonamido -indanylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI886005A7 (fi) | Nya, sulfhydrylgrupper innehaollande tricykliska laktamer och deras farmakologiska anvaendningsfoerfaranden. | |
| FI892454L (fi) | Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma. | |
| FI875727L (fi) | Nya oligosackarider, immunogener och vacciner och foerfarande foer framstaellning av saodana oligosackarider, immunogener och vacciner. | |
| FI874323A7 (fi) | Nya imidazo-benzoxazinoner, deras framstaellning och dessa foereningar innehaollande laekemedel. | |
| FI861153A0 (fi) | Nya jodpropargyletrar, foerfarande foer deras framstaellning och deras anvaendning. | |
| FI872841L (fi) | Nya kromoforfoereningar, solskyddskompositioner och foerfarande foer hindrande av solbraenna. | |
| FI870274A0 (fi) | Nya alkan- och alkoxialkanderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande bekaempningsmedel foer insekter och kvalster. | |
| FI871052A7 (fi) | Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI883347A7 (fi) | Nya 5-aminometylen-2,4 -imidazolidindioner och 5-aminometylen-4-tionoimidazolidin-4-oner. | |
| FI882385L (fi) | Fosforhaltiga hmg-coa -reduktasinhibitorer, foerfarande foer framstaellning daerav och nya mellanprodukter. | |
| FI875719A0 (fi) | Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. | |
| FI885811L (fi) | Nya ammoniumfoereningar, deras framstaellning och anvaendning. | |
| FI882477A7 (fi) | Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. | |
| FI875595A7 (fi) | Nya bicykliska difosfonatfoereningar, farmaceutiska kompositioner och foerfarande foer behandling av avvikande kalcium- och fosfatmetabolism. | |
| FI881816L (fi) | Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. | |
| FI873917A7 (fi) | Nya naftalin- och indanderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI875086A7 (fi) | Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. | |
| FI873934A7 (fi) | Nya naftylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI873243A7 (fi) | Nya 1,4-benzodiazepiner, deras framstaellning och anvaendning. | |
| FI873783A7 (fi) | Nya sulfonamido-etylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. | |
| FI885056L (fi) | Nya fluormetoxifenyldihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| FI872635A7 (fi) | Nya polypeptider, deras framstaellning och anvaendning. | |
| FI883745A7 (fi) | Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: FUJISAWA PHARMACEUTICAL CO., LTD. |